BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25845559)

  • 1. The WNT system: background and its role in bone.
    Lerner UH; Ohlsson C
    J Intern Med; 2015 Jun; 277(6):630-49. PubMed ID: 25845559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway.
    Appelman-Dijkstra NM; Papapoulos SE
    Nat Rev Endocrinol; 2018 Oct; 14(10):605-623. PubMed ID: 30181608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacology of bone anabolic agents].
    Matsumoto T
    Nihon Rinsho; 2015 Oct; 73(10):1639-44. PubMed ID: 26529924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
    Rossini M; Gatti D; Adami S
    Calcif Tissue Int; 2013 Aug; 93(2):121-32. PubMed ID: 23748710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt signaling: a key regulator of bone mass.
    Baron R; Rawadi G; Roman-Roman S
    Curr Top Dev Biol; 2006; 76():103-27. PubMed ID: 17118265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases.
    Boudin E; Fijalkowski I; Piters E; Van Hul W
    Semin Arthritis Rheum; 2013 Oct; 43(2):220-40. PubMed ID: 23433961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis.
    Martin TJ; Sims NA; Ng KW
    Osteoporos Int; 2008 Aug; 19(8):1125-38. PubMed ID: 18338097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Wnt inhibitors and the suppression of bone formation in multiple myeloma].
    Abe M
    Clin Calcium; 2013 Jun; 23(6):867-75. PubMed ID: 23719500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of modulating Wnt signaling pathway toward the development of bone anabolic agent.
    Krause U; Gregory CA
    Curr Mol Pharmacol; 2012 Jun; 5(2):164-73. PubMed ID: 21787289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parathyroid hormone and Wnt signaling].
    Tamura Y; Kaji H
    Clin Calcium; 2013 Jun; 23(6):847-52. PubMed ID: 23719497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Roles of Wnt signaling in bone metabolism].
    Kobayashi Y
    Clin Calcium; 2012 Nov; 22(11):1701-6. PubMed ID: 23103814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the anabolic response of bone using a cell population model.
    Buenzli PR; Pivonka P; Gardiner BS; Smith DW
    J Theor Biol; 2012 Aug; 307():42-52. PubMed ID: 22579551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new paradigm in the treatment of osteoporosis: Wnt pathway proteins and their antagonists.
    Chan A; van Bezooijen RL; Löwik CW
    Curr Opin Investig Drugs; 2007 Apr; 8(4):293-8. PubMed ID: 17458178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
    Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Anabolic Effect of Calcitriol with Osteoclast-Derived Wnt 10b Secretion.
    Lu CL; Shyu JF; Wu CC; Hung CF; Liao MT; Liu WC; Zheng CM; Hou YC; Lin YF; Lu KC
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30149605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches.
    Canalis E
    Nat Rev Endocrinol; 2013 Oct; 9(10):575-83. PubMed ID: 23938284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoblastic Wnts differentially regulate bone remodeling and the maintenance of bone marrow mesenchymal stem cells.
    Wan Y; Lu C; Cao J; Zhou R; Yao Y; Yu J; Zhang L; Zhao H; Li H; Zhao J; Zhu X; He L; Liu Y; Yao Z; Yang X; Guo X
    Bone; 2013 Jul; 55(1):258-67. PubMed ID: 23334081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Wnt signalling the final common pathway leading to bone formation?
    Milat F; Ng KW
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):52-62. PubMed ID: 19524639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Regulation of Bone Metabolism and Disorders by Wnt Signaling.
    Maeda K; Kobayashi Y; Koide M; Uehara S; Okamoto M; Ishihara A; Kayama T; Saito M; Marumo K
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling: a win for bone.
    Piters E; Boudin E; Van Hul W
    Arch Biochem Biophys; 2008 May; 473(2):112-6. PubMed ID: 18364235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.